- 1. FLT1
- [Gene product of the FLT1 proto-oncogene. A receptor tyrosine kinase, thought to regulate endothelial cell-cell or cell-matrix interactions during vascular development. ( NCI )] (UMLS (NCI) C0378516) =Amino Acid, Peptide, or Protein; Enzyme
| - 7. Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide
- (UMLS (NCI) C0879327) =Therapeutic or Preventive Procedure
|
- 2. FLT1
- [This gene is involved in cellular proliferation, differentiation and tyrosine kinase signal transduction. ( NCI )] (UMLS (NCI) C0812298) FLT1 Gene;
FMS-Related Tyrosine Kinase 1 (Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor) Gene =Gene or Genome | - 8. Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Tyrosinase
- (UMLS (NCI) C0796380) Flt3L/gp100/MART-1/TYR =Therapeutic or Preventive Procedure ;
|
- 3. FLT3
- [Fms-related receptor tyrosine kinase; growth factor receptor for hematopoietic stem and progenitor cells. (LocusLink) ( NCI )] (UMLS (NCI) C0251006) =Amino Acid, Peptide, or Protein; Receptor ;
| - 9. FLT3LG
- [This gene plays a role in the proliferation of hematopoietic progenitor cells. ( NCI )] (UMLS (NCI) C1333567) FLT3LG Gene;
FMS-Related Tyrosine Kinase 3 Ligand Gene =Gene or Genome |
- 4. FLT3
- [This gene plays a role in hematopoiesis and may function as a growth factor receptor. ( NCI )] (UMLS (NCI) C1333568) FLT3 Gene;
FMS-Related Tyrosine Kinase 3 Gene =Gene or Genome | - 10. FLT4
- [This gene plays an essential role in the development of embryonic cardiovasculature and lymphatic vessel formation. ( NCI )] (UMLS (NCI) C1333569) FLT4 Gene;
FMS-Related Tyrosine Kinase 4 Gene =Gene or Genome |
- 5. Flt3 Ligand/gp100 Antigen
- (UMLS (NCI) C0677845) =Therapeutic or Preventive Procedure ;
| - 11. FLT4 Ligand
- [Encoded by human VEGFC Gene (PDGF/VEGF Family), VEGFC is expressed in spleen, lymph node, thymus, appendix, bone marrow, heart, placenta, ovary, skeletal muscle, prostate, testis, colon, and small intestine, as well as fetal liver, lung, and kidney. Active in angiogenesis, endothelial growth, and vascular permeability, VEGFC may maintain adult lymphatic endothelium. A FLT4 ligand, VEGFC is a 419-amino acid 47 kD (precursor) disulfide-linked homodimeric secreted polypeptide with C-terminal cysteine-rich BR3P repeats and similar to VEGF and VEGFB/VRF. VEGFC can also activate endothelial VEGFR2 (KDR/FLK1). VEGFC proteolytic maturation generates isoforms with increased VEGFR3 activity; fully processed VEGFC activates VEGFR2. Mature VEGFC is mostly composed of two VEGF homology domains bound by non-covalent interactions. (OMIM, Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C0388911) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 6. Flt3 Ligand/gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase
- (UMLS (NCI) C0796381) Flt3L/gp100/IFA/MART-1/TYR =Therapeutic or Preventive Procedure ;
| |
home
